Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more
Demant A/S (WILLF) - Total Liabilities
Latest total liabilities as of December 2025: $29.09 Billion USD
Based on the latest financial reports, Demant A/S (WILLF) has total liabilities worth $29.09 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Demant A/S - Total Liabilities Trend (2002–2025)
This chart illustrates how Demant A/S's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Demant A/S Competitors by Total Liabilities
The table below lists competitors of Demant A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gruma SAB de CV
OTCGREY:GPAGF
|
USA | $2.86 Billion |
|
Corcept Therapeutics Incorporated
NASDAQ:CORT
|
USA | $188.85 Million |
|
Oil India Limited
NSE:OIL
|
India | ₹552.76 Billion |
|
PotlatchDeltic Corp
NASDAQ:PCH
|
USA | $1.27 Billion |
|
Brembo S.p.A.
OTCGREY:BRBOF
|
USA | $2.44 Billion |
|
HOCHTIEF Aktiengesellschaft
PINK:HOCFF
|
USA | $22.51 Billion |
|
JCHX Mining Management Co Ltd
SHG:603979
|
China | CN¥9.01 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Demant A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.96 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Demant A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Demant A/S (2002–2025)
The table below shows the annual total liabilities of Demant A/S from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $29.09 Billion | +27.55% |
| 2024-12-31 | $22.81 Billion | +7.53% |
| 2023-12-31 | $21.21 Billion | -0.41% |
| 2022-12-31 | $21.30 Billion | +26.16% |
| 2021-12-31 | $16.88 Billion | +23.67% |
| 2020-12-31 | $13.65 Billion | -3.57% |
| 2019-12-31 | $14.15 Billion | +30.13% |
| 2018-12-31 | $10.88 Billion | +23.75% |
| 2017-12-31 | $8.79 Billion | +2.41% |
| 2016-12-31 | $8.58 Billion | +8.77% |
| 2015-12-31 | $7.89 Billion | +40.02% |
| 2014-12-31 | $5.63 Billion | +6.78% |
| 2013-12-31 | $5.28 Billion | +11.85% |
| 2012-12-31 | $4.72 Billion | +8.66% |
| 2011-12-31 | $4.34 Billion | -0.01% |
| 2010-12-31 | $4.34 Billion | +30.63% |
| 2009-12-31 | $3.32 Billion | -1.82% |
| 2008-12-31 | $3.39 Billion | +2.88% |
| 2007-12-31 | $3.29 Billion | +33.58% |
| 2006-12-31 | $2.46 Billion | +15.29% |
| 2005-12-31 | $2.14 Billion | +19.02% |
| 2004-12-31 | $1.80 Billion | +20.27% |
| 2003-12-31 | $1.49 Billion | -4.54% |
| 2002-12-31 | $1.56 Billion | -- |